12 July 2024
By Sarah Lowden
Thousands of multiple sclerosis patients in England are to get access to a new injection that can help slow the progression of the condition and reduce time spent in hospital, NHS England said.
Patients receiving the drug ocrelizumab via an twice-yearly infusion, which takes 4 hours or more each time, can now be offered an injection that takes 10 minutes.